BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02841748-completion@plaintrial.com
DTSTAMP:20261027T140425Z
DTSTART;VALUE=DATE:20260625
SUMMARY:A Randomized\, Double-Blind Phase II Study of Adjuvant Pembrolizuma
 b Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the
  PATHWay Study — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT02841748
URL:https://plaintrial.com/trial/NCT02841748
END:VEVENT
END:VCALENDAR